Literature DB >> 9872419

Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action.

L Collis1, C Hall, L Lange, M Ziebell, R Prestwich, E A Turley.   

Abstract

Texas red-labeled hyaluronan (TR-HA) is rapidly taken up in a CD44 independent manner into ras-transformed 10T1/2 fibroblasts, where it accumulates in both cell ruffles/lamellae, the perinuclear area, and the nucleus. HA does not accumulate in the cell ruffles/lamellae of parental 10T1/2 cells. Addition of HA to ras-transformed cells promotes their random motility but has no effect on 10T1/2 cell motility. 10T1/2 cells can be modified to take up HA into cell ruffles by exposure to phorbol ester or direct microinjection of HA into cells. Both treatments significantly stimulate 10T1/2 cell motility.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872419     DOI: 10.1016/s0014-5793(98)01505-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

2.  Modular extracellular matrices: solutions for the puzzle.

Authors:  Monica A Serban; Glenn D Prestwich
Journal:  Methods       Date:  2008-05       Impact factor: 3.608

3.  Sequential gelation of tyramine-substituted hyaluronic acid hydrogels enhances mechanical integrity and cell viability.

Authors:  Ahmad Abu-Hakmeh; Amy Kung; Benjamin R Mintz; Sarah Kamal; James A Cooper; X Lucas Lu; Leo Q Wan
Journal:  Med Biol Eng Comput       Date:  2016-04-07       Impact factor: 2.602

4.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.

Authors:  Yoshihiro Nishida; Warren Knudson; Cheryl B Knudson; Naoki Ishiguro
Journal:  Exp Cell Res       Date:  2005-04-21       Impact factor: 3.905

6.  Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.

Authors:  Sophia Adamia; Tony Reiman; Mary Crainie; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

7.  Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.

Authors:  Abigail H Conrad; Yuntao Zhang; Elena S Tasheva; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

8.  Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.

Authors:  Hussaini Syed Sha Qhattal; Xinli Liu
Journal:  Mol Pharm       Date:  2011-07-05       Impact factor: 4.939

9.  Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging.

Authors:  Yuhan Lee; Haeshin Lee; Young Beom Kim; Jaeyoon Kim; Taeghwan Hyeon; Hyunwook Park; Phillip B Messersmith; Tae Gwan Park
Journal:  Adv Mater       Date:  2008-11-03       Impact factor: 30.849

10.  Synthesis, characterization and chondroprotective properties of a hyaluronan thioethyl ether derivative.

Authors:  Monica A Serban; Guanghui Yang; Glenn D Prestwich
Journal:  Biomaterials       Date:  2007-12-26       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.